DaVita HealthCare Partners Inc (DVA)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 2,262,201 2,296,448 2,281,206 2,285,388 2,245,510 2,196,458 2,191,013 2,129,720 2,087,799 2,011,506 1,915,202 1,896,587 1,875,950 1,721,955 1,804,413 1,810,218 1,781,346 1,874,747 1,867,238 1,821,233
Payables US$ in thousands 547,200 488,244 493,534 489,883 514,533 435,417 427,894 447,969 479,780 417,139 402,308 433,137 402,049 387,712 376,264 348,105 434,253 388,504 357,283 340,092
Payables turnover 4.13 4.70 4.62 4.67 4.36 5.04 5.12 4.75 4.35 4.82 4.76 4.38 4.67 4.44 4.80 5.20 4.10 4.83 5.23 5.36

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $2,262,201K ÷ $547,200K
= 4.13

DaVita HealthCare Partners Inc's payables turnover ratio, which measures how efficiently the company manages its accounts payable, has shown fluctuations over the periods provided.

The payables turnover ratio ranged from a high of 5.36 in March 2020 to a low of 4.10 in December 2020, indicating a decline in the company's ability to efficiently pay off its suppliers during that period. Subsequently, the ratio improved to 5.20 in March 2021 but then decreased again to 4.44 in September 2021.

Overall, the payables turnover ratio has shown some volatility but has generally remained within a range between 4 to 5 times over the reporting periods. This suggests that DaVita HealthCare Partners Inc has been managing its accounts payable effectively, although there have been some fluctuations in efficiency.

It is important for the company to monitor this ratio closely to ensure timely payments to suppliers while also optimizing its working capital management.


Peer comparison

Dec 31, 2024

Company name
Symbol
Payables turnover
DaVita HealthCare Partners Inc
DVA
4.13
Progyny Inc
PGNY
11.56
Sotera Health Co
SHC
6.65